Literature DB >> 33989538

Variation in Care of Community and Nursing Home Residents Who Died of COVID-19 in Ontario, Canada.

Kevin A Brown1, Nick Daneman2, Sarah A Buchan3, Adrienne K Chan2, Nathan M Stall2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33989538      PMCID: PMC8057761          DOI: 10.1016/j.jamda.2021.04.008

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


× No keyword cloud information.
Worldwide, nursing home residents have experienced disproportionately high COVID-19 mortality because of the intersection of congregate living, multimorbidity, and advanced age. Among 12 OECD countries in July, Canada had the highest proportion of COVID-19 deaths in nursing home residents (78%), raising concerns about a skewed pandemic response that averted much transmission and mortality in community-dwelling residents, without adequately protecting those in nursing homes. In Canada's most populous province of Ontario, there was no official policy denying hospitalizations for nursing home residents with COVID-19, yet media reports and a provincial commission suggest that resident transfers to hospital were strongly discouraged at the onset of the pandemic. , To investigate this, we measured temporal variations in hospitalizations among community and nursing home–dwelling decedents with COVID-19 during the first and second waves of the pandemic.

Methods

We conducted a retrospective cohort study of Ontario residents with COVID-19 who died between March 11, 2020 (first COVID-19 death in Ontario), and December 31, 2020. COVID-19 is reportable under provincial public health legislation, and all laboratories relay positive nucleic acid amplification tests to local public health units, who subsequently investigate and enter case data, including demographics, address, and date of hospitalization and of death, into the provincial reportable diseases surveillance system. The surveillance data have been validated for hospitalization (sensitivity = 87%, specificity = 98%) and death (sensitivity = 97%, specificity = 99%). We examined hospitalization prior to death as a function of 4 factors: nursing home residence vs community-dwelling (ie, non-nursing home), age in years (<70, 70-79, 80-89, ≥90), gender, and period of death (first wave: March-April, May, June-July 2020; second wave: August-October, November, December 2020). The study received a waiver of consent from the research ethics board of Public Health Ontario.

Results

A total of 4770 people with confirmed COVID-19 died in Ontario from March to December, 2020 (Table 1 ), of whom 2155 (45.2%) were hospitalized prior to death (median: 9 days before death, interquartile range: 4-19). Among nursing home decedents (n = 2897), 24.1% were hospitalized prior to death, but this varied substantially from a low of 16.4% in March-April (peak of wave 1) to a high of 41.1% in June-July (nadir of wave 1). Among community-dwelling decedents (n = 1873), admission to acute care before death was higher (77.7%) and remained relatively stable throughout the first and second waves. Similar temporal trends for nursing home decedents were apparent in age-stratified analyses. Decedents who were older were less likely to be hospitalized than younger decedents in both community (79.2% <70 vs 69.4% ≥90) and nursing home (40.7% <70 vs 19.0% ≥90) settings. Decedents who were women were less likely to be hospitalized compared with men in both community (74.4% women vs 80.4% men) and nursing home (21.9% women vs 27.6% men) settings.
Table 1

Admissions to Hospital Prior to Death Among Community-Dwelling Adults and Nursing Home Residents Who Died With COVID-19 in Ontario, Canada, March to December 2020 (N = 4770)

nProportion of Total Ontario Deaths Among Nursing Home Residents (%)Community Residents
Nursing Home Residents
nHospitalized Prior to Death, n (%)P ValuenHospitalized Prior to Death, n (%)P Value
Total477060.718731456 (77.7)2897699 (24.1)
Month (2020)<.001<.001
 March-April157066.1533426 (79.9)1037170 (16.4)
 May103670.5306253 (82.7)730197 (27.0)
 June-July31054.2142127 (89.4)16869 (41.1)
 August-October28642.3165124 (75.2)12136 (29.8)
 November54356.9234163 (69.7)309108 (35.0)
 December102551.9493363 (73.6)532119 (22.4)
Age, y<.001<.001
 <7061028.2438347 (79.2)17270 (40.7)
 70-7986650.8426345 (81.0)440135 (30.7)
 80-89172864.7610487 (79.8)1118272 (24.3)
 ≥90156674.5399277 (69.4)1167222 (19.0)
Gender.002<.001
 Male226452.81068859 (80.4)1196330 (27.6)
 Female246967.7798594 (74.4)1671366 (21.9)

P values for differences in proportions were based on Pearson chi-square test.

Deaths with unknown age (n = 1) or unknown, trans, or other gender (n = 37) are not presented above.

Admissions to Hospital Prior to Death Among Community-Dwelling Adults and Nursing Home Residents Who Died With COVID-19 in Ontario, Canada, March to December 2020 (N = 4770) P values for differences in proportions were based on Pearson chi-square test. Deaths with unknown age (n = 1) or unknown, trans, or other gender (n = 37) are not presented above.

Discussion

Only a minority of Ontario nursing home residents who died of COVID-19 at the onset of the pandemic in Canada were hospitalized before death. Although many nursing home residents have advance directives precluding hospitalization, the low admission rates observed in March-April 2020 were inconsistent with both higher admission rates in subsequent months and comparatively stable month-to-month rates among community-dwelling adults. Our study suggests that variations in access to acute care services, whether due to informal policies or not, may partly explain high mortality among residents and variations in the proportion of COVID-19 deaths occurring in nursing homes, which, in the United States, ranged from 18% in Nevada to 79% in New Hampshire. Our study lacked data on factors influencing hospitalization, including resident acuity at the time of infection identification, advance directives and engagement of family, and home outbreak severity and staffing shortages. Overall, we identified low levels of hospitalization for nursing home residents dying of COVID-19 at the onset of the pandemic, which may have contributed to the particularly high concentration of COVID-19 mortality in Ontario's nursing homes.
  5 in total

Review 1.  COVID-19 prevalence and mortality in longer-term care facilities.

Authors:  Andrew T Levin; Juulia Jylhävä; Dorota Religa; Laura Shallcross
Journal:  Eur J Epidemiol       Date:  2022-04-10       Impact factor: 12.434

2.  Excess Mortality in Long-Term Care Residents With and Without Personal Contact With Family or Friends During the COVID-19 Pandemic.

Authors:  Rachel D Savage; Paula A Rochon; Yingbo Na; Rachel Strauss; Kevin A Brown; Andrew P Costa; Sudeep Gill; Jennie Johnstone; Peter Tanuseputro; Nathan M Stall; Pat Armstrong
Journal:  J Am Med Dir Assoc       Date:  2021-12-18       Impact factor: 7.802

3.  Predictors of all-cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS-CoV-2.

Authors:  Mackenzie A Hamilton; Ying Liu; Andrew Calzavara; Maria E Sundaram; Mohamed Djebli; Dariya Darvin; Stefan Baral; Rafal Kustra; Jeffrey C Kwong; Sharmistha Mishra
Journal:  Influenza Other Respir Viruses       Date:  2022-05-24       Impact factor: 5.606

4.  Initial health care costs for COVID-19 in British Columbia and Ontario, Canada: an interprovincial population-based cohort study.

Authors:  Teresa C O Tsui; Seraphine Zeitouny; Karen E Bremner; Douglas C Cheung; Carol Mulder; Ruth Croxford; Lisa Del Giudice; Lauren Lapointe-Shaw; Andrew Mendlowitz; William W L Wong; Nathan Perlis; Beate Sander; Paulos Teckle; George Tomlinson; Jennifer D Walker; Kamil Malikov; Kimberlyn M McGrail; Stuart Peacock; Girish S Kulkarni; Reka E Pataky; Murray D Krahn
Journal:  CMAJ Open       Date:  2022-09-20

5.  Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments.

Authors:  Maria Sundaram; Sharifa Nasreen; Andrew Calzavara; Siyi He; Hannah Chung; Susan E Bronskill; Sarah A Buchan; Mina Tadrous; Peter Tanuseputro; Kumanan Wilson; Sarah Wilson; Jeffrey C Kwong
Journal:  Vaccine       Date:  2021-07-23       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.